Jiangshan Lian
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 3
- Neurology top 10%
- Long-Term Effects of COVID-19 5
- Hepatology top 10%
- Hepatitis C virus research 13
- Liver Disease and Transplantation 5
-
- Hepatitis B Virus Studies 11
- Liver Disease Diagnosis and Treatment 10
-
- Drug-Induced Hepatotoxicity and Protection 4
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jiangshan Lian
32 papers receiving 491 citations
Peers
Comparison fields: 5 of 89
- Infectious Diseases 255
- Neurology 163
- Hepatology 67
- Epidemiology 125
- Oncology 79
Countries citing papers authored by Jiangshan Lian
This map shows the geographic impact of Jiangshan Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangshan Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangshan Lian more than expected).
Fields of papers citing papers by Jiangshan Lian
This network shows the impact of papers produced by Jiangshan Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangshan Lian. The network helps show where Jiangshan Lian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiangshan Lian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 3 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 7 | |
| 17 | 2016 | 7 | |
| 18 | 2015 | 28 | |
| 19 | 2014 | 9 | |
| 20 | 2013 | 12 |
About Jiangshan Lian
Jiangshan Lian is a scholar working on Hepatology, Pharmacology and Epidemiology, having authored 35 papers that have together received 505 indexed citations. Recurring topics across this work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers), COVID-19 Clinical Research Studies (5 papers), Liver Disease and Transplantation (5 papers), Long-Term Effects of COVID-19 (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Infectious Diseases (255 citations), Neurology (163 citations) and Hepatology (67 citations). Jiangshan Lian has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yingfeng Lu, Lanjuan Li, Jianhua Hu, Jueqing Gu, Huan Cai, Ciliang Jin, Jifang Sheng, Chanyuan Ye, Shanyan Zhang and Xiaoli Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.